BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25444916)

  • 1. Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer.
    Ye M; Zhang J; Zhang J; Miao Q; Yao L; Zhang J
    Cancer Lett; 2015 Feb; 357(1):196-205. PubMed ID: 25444916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
    Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion.
    Zhan JW; Jiao DM; Wang Y; Song J; Wu JH; Wu LJ; Chen QY; Ma SL
    Thorac Cancer; 2017 Sep; 8(5):461-470. PubMed ID: 28660665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-339-5p downregulation contributes to Taxol resistance in small-cell lung cancer by targeting α1,2-fucosyltransferase 1.
    Gan CZ; Li G; Luo QS; Li HM
    IUBMB Life; 2017 Nov; 69(11):841-849. PubMed ID: 28940895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction.
    Fortunato O; Boeri M; Moro M; Verri C; Mensah M; Conte D; Caleca L; Roz L; Pastorino U; Sozzi G
    Cell Death Dis; 2014 Dec; 5(12):e1564. PubMed ID: 25501825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
    Jiao DM; Yan L; Wang LS; Hu HZ; Tang XL; Chen J; Wang J; Li Y; Chen QY
    PLoS One; 2017; 12(2):e0172470. PubMed ID: 28231299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin increases crizotinib sensitivity through the inactivation of autophagy via epigenetic modulation of the miR-142-5p/Ulk1 axis in non-small cell lung cancer.
    He YZ; Yu SL; Li XN; Bai XH; Li HT; Liu YC; Lv BL; Zhao XM; Wei D; Zhang HL; Li FN; Li G; Li S
    Cancer Biomark; 2022; 34(2):297-307. PubMed ID: 34957997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-324-5p upregulation potentiates resistance to cisplatin by targeting FBXO11 signalling in non-small cell lung cancer cells.
    Ba Z; Zhou Y; Yang Z; Xu J; Zhang X
    J Biochem; 2019 Dec; 166(6):517-527. PubMed ID: 31778188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells.
    Jiang L; Huang Q; Chang J; Wang E; Qiu X
    Exp Lung Res; 2011 Sep; 37(7):387-98. PubMed ID: 21777146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
    Gao W; Chan JY; Wong TS
    Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.
    Borzi C; Calzolari L; Centonze G; Milione M; Sozzi G; Fortunato O
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.
    Hsu KW; Fang WL; Huang KH; Huang TT; Lee HC; Hsieh RH; Chi CW; Yeh TS
    Oncotarget; 2016 Jun; 7(25):38036-38051. PubMed ID: 27191259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activation.
    Ong PS; Wang L; Chia DM; Seah JY; Kong LR; Thuya WL; Chinnathambi A; Lau JY; Wong AL; Yong WP; Yang D; Ho PC; Sethi G; Goh BC
    Cancer Lett; 2016 Oct; 381(1):49-57. PubMed ID: 27461583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel microRNA hsa-miR-CHA1 regulates cell proliferation and apoptosis in human lung cancer by targeting XIAP.
    Yoo JK; Lee JM; Kang SH; Jeon SH; Kim CM; Oh SH; Kim CH; Kim NK; Kim JK
    Lung Cancer; 2019 Jun; 132():99-106. PubMed ID: 31097102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
    Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade- and mitochondria-dependent pathways.
    Wu SH; Hang LW; Yang JS; Chen HY; Lin HY; Chiang JH; Lu CC; Yang JL; Lai TY; Ko YC; Chung JG
    Anticancer Res; 2010 Jun; 30(6):2125-33. PubMed ID: 20651361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDL1 Regulation by p53 via miR-34.
    Cortez MA; Ivan C; Valdecanas D; Wang X; Peltier HJ; Ye Y; Araujo L; Carbone DP; Shilo K; Giri DK; Kelnar K; Martin D; Komaki R; Gomez DR; Krishnan S; Calin GA; Bader AG; Welsh JW
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26577528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.